Vincristine, irinotecan, and temozolomide in patients with relapsed and refractory neuroblastoma.

被引：1
|
作者：
Zhu, Jia [1 ]
Zhen, Zijun [1 ]
Wang, Juan [1 ]
Chen, Tingting [1 ]
Lu, Suying [1 ]
Sun, Feifei [1 ]
Huang, Junting [1 ]
Que, Yi [1 ]
Zhang, Lian [1 ]
Zhang, Yizhuo [1 ]
Sun, Xiaofei [1 ]
机构：
[1] Sun Yat Sen Univ, Canc Ctr, Guangzhou, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期
关键词：
D O I：
10.1200/JCO.2021.39.15_suppl.e22009
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e22009
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Vincristine, Irinotecan, and Temozolomide in Patients With Relapsed/Refractory Neuroblastoma
    Zhu, Jia
    Wang, Juan
    Sun, Feifei
    Zhen, Zijun
    Chen, Tingting
    Lu, Suying
    Huang, Junting
    Zhang, Yizhuo
    Sun, Xiaofei
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [2] Vincristine, irinotecan, and temozolomide in patients with relapsed and refractory Ewing sarcoma
    Raciborska, Anna
    Bilska, Katarzyna
    Drabko, Katarzyna
    Chaber, Radoslaw
    Pogorzala, Monika
    Wyrobek, Elzbieta
    Polczynska, Katarzyna
    Rogowska, Elzbieta
    Rodriguez-Galindo, Carlos
    Wozniak, Wojciech
    PEDIATRIC BLOOD & CANCER, 2013, 60 (10) : 1621 - 1625
  • [3] Irinotecan plus temozolomide for relapsed or refractory neuroblastoma
    Kushner, Brian H.
    Kramer, Kim
    Modak, Shakeel
    Cheung, Nai-Kong V.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (33) : 5271 - 5276
  • [4] A PHARMACOKINETIC AND PHARMACOGENETIC STUDY OF ALISERTIB COMBINED WITH IRINOTECAN AND TEMOZOLOMIDE IN CHILDREN AND ADOLESCENTS WITH RELAPSED OR REFRACTORY NEUROBLASTOMA.
    Kudgus, R. A.
    Fox, E.
    McGovern, R. M.
    Moorthy, G.
    Marachelian, A.
    DuBois, S. G.
    Reid, J. M.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2015, 97 : S68 - S68
  • [5] Phase II study of 131I-MIBG with vincristine and 5 days of irinotecan for patients with relapsed or refractory neuroblastoma.
    DuBois, Steven G.
    Allen, M. Shelly
    Bent, Melissa
    Hilton, Joan
    Hollinger, Fabienne
    Courtier, Jesse
    Hawkins, Randall
    Mosse, Yael P.
    Matthay, Katherine K.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [6] Temozolomide in resistant or relapsed neuroblastoma.
    Donfrancesco, A
    Milano, GM
    Jenkner, A
    de Sio, L
    Fidani, P
    Ilari, I
    Cozza, R
    Castellano, A
    de Laurentis, C
    Dominici, C
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 805S - 805S
  • [7] VINCRISTINE, IRINOTECAN, AND TEMOZOLOMIDE FOR RELAPSED RHABDOMYOSARCOMA
    Setty, Bhuvana
    Stanek, Joseph
    Elgendy, Mohamed
    Mascarenhas, Leo
    Miller, Alexandra
    Bagatell, Rochelle
    Nicholls, Lauren
    Lysecki, David
    Gupta, Abha
    PEDIATRIC BLOOD & CANCER, 2016, 63 : S64 - S65
  • [8] Phase II Trial of Alisertib in Combination with Irinotecan and Temozolomide for Patients with Relapsed or Refractory Neuroblastoma
    DuBois, Steven G.
    Mosse, Yael P.
    Fox, Elizabeth
    Kudgus, Rachel A.
    Reid, Joel M.
    McGovern, Renee
    Groshen, Susan
    Bagatell, Rochelle
    Maris, John M.
    Twist, Clare J.
    Goldsmith, Kelly
    Granger, M. Meaghan
    Weiss, Brian
    Park, Julie R.
    Macy, Margaret E.
    Cohn, Susan L.
    Yanik, Greg
    Wagner, Lars M.
    Hawkins, Randall
    Courtier, Jesse
    Lai, Hollie
    Goodarzian, Fariba
    Shimada, Hiroyuki
    Boucher, Najee
    Czarnecki, Scarlett
    Luo, Chunqiao
    Tsao-Wei, Denice
    Matthay, Katherine K.
    Marachelian, Araz
    CLINICAL CANCER RESEARCH, 2018, 24 (24) : 6142 - 6149
  • [9] Vincristine, Irinotecan, and Temozolomide as a Salvage Regimen for Relapsed or Refractory Sarcoma in Children and Young Adults
    Ju, Hee Young
    Park, Meerim
    Lee, Jun Ah
    Park, Hyeon Jin
    Park, Seog Yun
    Kim, June Hyuk
    Kang, Hyun Guy
    Yang, Hee Chul
    Park, Byung-Kiu
    CANCER RESEARCH AND TREATMENT, 2022, 54 (02): : 563 - 571
  • [10] VIncristine, irinotecan, and temozolomide in children and adolescents with relapsed rhabdomyosarcoma
    Setty, Bhuvana A.
    Stanek, Joseph R.
    Mascarenhas, Leo
    Miller, Alexandra
    Bagatell, Rochelle
    Okcu, Fatih
    Nicholls, Lauren
    Lysecki, David
    Gupta, Abha A.
    PEDIATRIC BLOOD & CANCER, 2018, 65 (01)
12345